Nonsurgical Therapies for Basal Cell Carcinoma: A Review
- PMID: 28433227
- DOI: 10.1016/j.ad.2017.01.018
Nonsurgical Therapies for Basal Cell Carcinoma: A Review
Abstract
Basal cell carcinoma (BCC) is the most prevalent malignant tumor in humans and the local destruction of tissue that can result from excision has a significant impact on well-being. Treating BCC is costly for health care systems given the high incidence of this tumor, especially in older patients. Standard treatment involves either resection with histologic assessment of margins or Mohs micrographic surgery. Surgery is sometimes contraindicated, however, due to the presence of significant comorbidity or high cosmetic expectations. For such patients, nonsurgical treatments have become available. These alternatives can offer good local control of disease, preserve function, and achieve excellent cosmetic results.
Keywords: Basal cell carcinoma; Carcinoma basocelular; Cáncer de piel; Skin cancer; Tratamiento; Treatment.
Copyright © 2017 AEDV. Publicado por Elsevier España, S.L.U. All rights reserved.
Similar articles
-
Nonsurgical treatment of nonmelanoma skin cancer in the mature patient.Clin Dermatol. 2018 Mar-Apr;36(2):177-187. doi: 10.1016/j.clindermatol.2017.10.009. Epub 2017 Nov 3. Clin Dermatol. 2018. PMID: 29566922 Review.
-
[Surgical vs nonsurgical treatment of basal cell carcinoma].Actas Dermosifiliogr. 2010 Oct;101(8):683-92. Actas Dermosifiliogr. 2010. PMID: 20965011 Spanish.
-
5% imiquimod cream and reflectance-mode confocal microscopy as adjunct modalities to Mohs micrographic surgery for treatment of basal cell carcinoma.Dermatol Surg. 2004 Dec;30(12 Pt 1):1462-9. doi: 10.1111/j.1524-4725.2004.30504.x. Dermatol Surg. 2004. PMID: 15606733 Clinical Trial.
-
New perspectives in the management of basal cell carcinoma.Actas Dermosifiliogr. 2014 Nov;105(9):874-5. doi: 10.1016/j.ad.2014.04.007. Epub 2014 Jun 14. Actas Dermosifiliogr. 2014. PMID: 24934656 Review. English, Spanish. No abstract available.
-
Treatment of advanced basal cell carcinoma with sonidegib: perspective from the 30-month update of the BOLT trial.Future Oncol. 2018 Mar;14(6):515-525. doi: 10.2217/fon-2017-0457. Epub 2017 Nov 9. Future Oncol. 2018. PMID: 29119833 Clinical Trial.
Cited by
-
Relationship between androgen receptor and epidermal growth factor receptor determines aggressive behavior of cutaneous basal cell carcinoma.Sci Prog. 2025 Jul-Sep;108(3):368504251369587. doi: 10.1177/00368504251369587. Epub 2025 Aug 12. Sci Prog. 2025. PMID: 40790975 Free PMC article.
-
Basal Cell Carcinoma: A Patient and Physician's Experience.Dermatol Ther (Heidelb). 2018 Sep;8(3):329-337. doi: 10.1007/s13555-018-0245-2. Epub 2018 Jun 2. Dermatol Ther (Heidelb). 2018. PMID: 29860652 Free PMC article.
-
Non-melanoma skin cancers: physio-pathology and role of lipid delivery systems in new chemotherapeutic treatments.Neoplasia. 2022 Aug;30:100810. doi: 10.1016/j.neo.2022.100810. Epub 2022 May 29. Neoplasia. 2022. PMID: 35649306 Free PMC article. Review.
-
Topical and Intralesional Immunotherapy for the Management of Basal Cell Carcinoma.Cancers (Basel). 2024 Jun 4;16(11):2135. doi: 10.3390/cancers16112135. Cancers (Basel). 2024. PMID: 38893254 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical